ARTICLES

Highly Efficient Synthesis of 1H-Indazole-3-carboxylic Acid Derivatives via Diazotization Reaction

  • Changming Xu ,
  • Jincheng Huang
Expand
  • School of Chemistry and Chemical Engineering, Lanzhou Jiaotong University, Lanzhou 730070
*Corresponding author.E-mail:

Received date: 2021-03-04

  Revised date: 2021-04-06

  Online published: 2021-05-08

Supported by

National Natural Science Foundation of China(21662024); National Natural Science Foundation of China(22061025); Natural Science Foundation of Gansu Province(20JR10RA220); Foundation of a Hundred Youth Talents Training Program of Lanzhou Jiaotong University

Abstract

Direct conversion of ortho-aminobenzacetamides and ortho-aminobenzacetates to the corresponding 1H-indazole- 3-carboxylic acid derivatives under the action of diazotization reagents was reported. This method features operational simplicity, mild reaction conditions, rapid reaction rates, high yields, wide substrate scope, offering an efficient and concise route to synthesis of 1H-indazole-3-carboxylic acid derivatives. The drugs granisetron and lonidamine were synthesized successfully using this protocol with 46% and 60% total yields, respectively. Preliminary mechanistic study suggests that diazonium salt is a key intermediate.

Cite this article

Changming Xu , Jincheng Huang . Highly Efficient Synthesis of 1H-Indazole-3-carboxylic Acid Derivatives via Diazotization Reaction[J]. Chinese Journal of Organic Chemistry, 2021 , 41(8) : 3256 -3263 . DOI: 10.6023/cjoc202103008

References

[1]
For selected reviews, see:
[1]
(a) Schmidt, A.; Beutler, A.; Snovydovych, B. Eur. J. Org. Chem. 2008, 4073.
[1]
(b) Ghosh, S.; Mondal, S.; Hajra, A. Adv. Synth. Catal. 2020, 362, 3768.
[1]
For selected examples, see:
[1]
(c) Zhang, X.; Pan, Y.; Liang, P.; Ma, X.; Jiao, W.; Shao, H. Adv. Synth. Catal. 2019, 361, 5552.
[1]
(d) Hunter, C. J.; Boyd, M. J.; May, G. D.; Fimognari, R. J. Org. Chem. 2020, 85, 8732.
[2]
Vernekar, S. K. V.; Hallaq, H. Y.; Clarkson, G.; Thompson, A. J.; Silvestri, L.; Lummis, S. C. R.; Lochner, M. J. Med. Chem. 2010, 53, 2324.
[3]
Gatto, M. T.; Tita, B.; Artico, M.; Saso, L. Contraception 2002, 65, 277.
[4]
Kuang, S.-M.; Zhang, P. US 20110172428, 2011.
[5]
Nakano, H.; Hasegawa, T.; Imamura, R.; Saito, N.; Kojima, H.; Okabe, T.; Nagano, T. Bioorg. Med. Chem. Lett. 2016, 26, 2370.
[6]
Snyder, H. R.; Thompson, C. B.; Hinman, R. L. J. Am. Chem. Soc. 1952, 74, 2009.
[7]
Xiong, X.; Jiang, Y.; Ma, D. Org. Lett. 2012, 14, 2552.
[8]
(a) Ferrari, M.; Ripa, A.; Ripa, G. Sisti, M. J. Heterocycl. Chem. 1989, 26, 531.
[8]
(b) Han, B.; Yang, F.; Wang, L. CN 104370888, 2015.
[9]
Yoshida, T.; Matsuura, N.; Yamamoto, K.; Doi, M.; Shimada, K.; Morie, T.; Kato, S. Heterocycles 1996, 43, 2701.
[10]
Jin, T.; Yamamoto, Y. Angew. Chem., Int. Ed. 2007, 46, 3323.
[11]
Alaime, T.; Daniel, M.; Hiebel, M.-A.; Pasquinet, E.; Suzenet, F.; Guillaumet, G. Chem. Commun. 2013, 54, 8411.
[12]
(a) Wang, H.; Zhao, Z. CN 103787978, 2014.
[12]
(b) Tang, M.; Kong, Y.; Chu, B.; Feng, D. Adv. Synth. Catal. 2016, 358, 926.
[12]
(c) Tang, M.; Kong, Y.; Chu, B. CN 106316958, 2017.
[13]
(a) Rüchardt, C.; Hassmann, V. Liebigs Ann. Chem. 1980, 908.
[13]
(b) Bartsch, R.; Yang, I.-W. J. Heterocycl. Chem. 1984, 21, 1063.
[13]
(c) Schumann, P.; Collot, V.; Hommet, Y.; Gsell, W.; Dauphin, F.; Sopkova, J.; MacKenzie, E. T.; Duval, D.; Boulouard, M.; Rault, S. Bioorg. Med. Chem. Lett. 2001, 11, 1153.
[14]
Zhu, J.; Mao, J.; Yang, M.; Wu, X. CN 102911174, 2013.
[15]
For selected examples, see:
[15]
(a) Bermudez, J.; Fake, C. S.; Joiner, G. F.; Joiner, K. A.; King, F. D.; Miner, W. D.; Sanger, G. J. J. Med. Chem. 1990, 33, 1924.
[15]
(b) Mu, L.; Muller Herde, A.; Ruefli, P. M.; Sladojevich, F.; Milicevic Sephton, S.; Kramer, S. D.; Thompson, A. J.; Schibli, R.; Ametamey, S. M.; Lochner, M. ACS Chem. Neurosci. 2016, 7, 1552.
[15]
(c) Coomber, C. E.; Laserna, V.; Martin, L. T.; Smith, P. D.; Hailes, H. C.; Portera, M. J.; Sheppard, T. D. Org. Biomol. Chem. 2019, 17, 6465.
[15]
(d) Opie, C. R.; Noda, H.; Shibasaki, M.; Kumagai, N. Chem-Eur. J. 2019, 25, 4648.
[16]
(a) Dalmases Barjoan, P.; Puig Torres, S. WO 2003080606, 2003.
[16]
(b) Ward, N.; Jones, D. A.; Jacewicz, V. W. WO 9730049, 1997.
[17]
SmithKline Beecham PLC, AT406770, 2000.
[18]
Xie, Y.; Zhang, S.; Ge, X.; Ma, W.; He, X.; Zhao, Y.; Ye, J.; Zhang, H.; Wang, A.; Liu, Z. Appl. Organomet. Chem. 2020, 34, e5589.
[19]
(a) Yin, J.; Xia, M.; Dong, H.; Ding, F.; Xu, S. CN 103159679, 2013.
[19]
(b) Liu, C.; Dong, Z.; Zhang, W.; Tang, P.; Gao, J. CN 1594297, 2005.
[19]
(c) Hou, C.-J.; Luo, B.; Huo, D.-Q. Prog. Pharm. Sci. 2006, 30, 235. (in Chinese)
[19]
(侯长军, 罗斌, 霍丹群, 药学进展, 2006, 30, 235.)
[20]
Senadi, G. C.; Wang, J.-Q.; Gore, B. S.; Wang, J.-J. Adv. Synth. Catal. 2017, 359, 2747.
[21]
(a) Dell'Erba, C.; Novi, M.; Petrillo, G.; Tavani, C. Tetrahedron 1994, 50, 3529.
[21]
(b) Zhao, X.; Liu, Q.; Feng, R.; Zeng, X.; Wentrup, C. Eur. J. Org. Chem. 2019, 2019, 6945.
[22]
Buchstaller, H.-P.; Wilkinson, K.; Burek, K.; Nisar, Y. Synthesis 2011, 3089.
Outlines

/